Combination therapy of biologic and non-biologic systemic agents in psoriasis: A narrative review of real-world evidence and clinical positioning
Biologic therapies have substantially improved outcomes in moderate-to-severe psoriasis; however, in real-world practice, secondary loss of efficacy - often driven by immunogenicity and ultimately reflected in reduced treatment persistence - remains an important clinical challenge. Although biologic-disease-modifying...